Cardiovascular
8 articole · RSS
Medicamentele pentru boli de inima continua sa fie cel mai important segment al pietei farmaceutice
"Ca valoare segmentul cardiovascular este aproape triplu comparativ cu 2004, iar ca volum este dublu. Numarul zilelor de tratament s-a dublat in acest interval, ceea ce inseamna o crestere a numarului de bolnavi, dar si ca pentru multi dintre cei care nu se pu...
Servier gains top 5 position with cardiovascular drugs
Servier, France's biggest independent drug maker, has gained a position among the top five pharmaceutical companies in Romania after it banked on cardiovascular products, given the rise in t...
Antibiotice gains ground on cardiovascular segment
Antibiotice, one of the leading local drug producers, saw 10 million RON (3 million euros) in sales on the cardiovascular drugs segment in 2007, up 67% on 2006. The cardiovascular segment wa...
Cardiovascular drugs take Sanofi's business to over 115m euros
Sanofi-Aventis, the third largest player on the Romanian drug market, estimates it will see an over 15% increase in sales this year against 2006. "We expect our growth rate to exceed the mar...
Cardiovascular drug market set to reach 300m euros
Cardiovascular drug market set to reach 300m euros
Cardiovascular drugs support AstraZeneca
Cardiovascular drugs support AstraZeneca
Cardiovascular drugs to aid Sicomed growth
Cardiovascular drugs to aid Sicomed growth
"Studiul de la Framingham", inca biblia riscului cardiovascular
Pentru a obtIne un beneficiu maxim in combaterea bolilor cardiovasculare este necesar nu numai un diagnostic precoce ci mai ales identificarea factorilor de risc . Aceasta reprezinta o preoc...